Neurotransmitters such as dopamine, serotonin, and gamma-aminobutyric acid (GABA) play pivotal roles in addiction. Dopamine, often linked to the brain's reward system, is excessively released during substance use, reinforcing the behavior and creating a cycle of dependency. Serotonin dysregulation can lead to mood disturbances, increasing susceptibility to addiction. GABA, a neurotransmitter responsible for calming the brain, becomes imbalanced, leading to heightened anxiety and withdrawal symptoms. These disruptions alter neural pathways, making it challenging to break free from addiction. Recovery often focuses on restoring neurotransmitter balance through pharmacological interventions and behavioral therapies. Understanding the role of neurotransmitters sheds light on addiction's complexity, emphasizing the importance of tailored treatment strategies that address these biochemical changes for sustainable recovery.
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Gangstalking is real, should be studied
Sam Vaknin, Southern Federal University, United Kingdom
Title : Decoding aggression, violence, and substance use in adolescents with conduct disorders: Neurochemical pathways and interventions
Ann Marie Leonard Zabel, Curry College, United States
Title : Sensoria driven genetic decoupling and impaired areal integration in diseases of agency
Denis Larrivee, University of Navarra, Spain
Title : Positive outcome of adherence to the reward deficiency syndrome solution system treatment plan: A longitudinal study
Elizabeth Dale Gilley, The Elle Foundation, United States